Relationship of five inflammatory gene polymorphisms with morbidity and mortality in 533 patients admitted to an ICU

Inflammation

Volumn 29, Issue 2-3, 2005, Pages 1-7

  Ortlepp, Jan R ^a   Graf, Jürgen ^a   Vesper, Katharina ^a   Schmitz, Fabian ^a   Mevissen, Vera ^a   Sucigan, Sebastian ^a   Kersten, Alexander ^a   Weber, Christian ^a   Janssens, Uwe ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b St Antonius Hospital   (Germany)

Author keywords

Genetic polymorphism; ICU; Morbidity; Mortality

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR2; CONNECTIVE TISSUE GROWTH FACTOR; GENOMIC DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OLIGONUCLEOTIDE PROBE;

EID: 33748376497     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-006-9000-4     Document Type: Article

References (30)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
2. Alexander, R. W. 1994. Inflammation and coronary artery disease. N. Engl. J. Med. 331:468-469.
3. Ridker, P. M. 2001. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet 358:946-948.
4. Mehta, J. L., T. G. P, Saldeen, and K. Rand. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol. 31:1217-1225.
5. Rupprecht, H. J., S. Blankenberg, C. Bickel, G. Rippin, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer. 2001. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25-31.
6. Mira, J. P., A. Cariou, F. Grall, C. Delclaux, M. R. Losser, F. Heshmati, C. Cheval, M. Monchi, J. L. Teboul, F. Riche, G. Leleu, L. Arbibe, A. Mignon, M. Delpech, and J. F. Dhainaut. 1999. Association of TNF2, a TNF-alpha promotor polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568.
7. Tang, G. J., S. L. Huang, H. W. Yien, W. S. Chen, C. W. Chi, C. W. Wu, W. Y. Lui, J. H. Chiu, and T. Y. Lee. 2000. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit. Care. Med. 28:2733-2736.
8. Yende, S., M. W. Quasney, E. Tolley, Q. Zhang, and R. G. Wunderink. 2003. Association of tumor necrosis factor gene polymorphism and prolonged mechanical ventilation after coronary artery bypass surgery. Crit. Care. Med. 31:133-140.
9. Ohnishi, H., T. Oka, S. Kusachi, T. Nakanishi, K. Takeda, M. Nakahama, M. Doi, T. Murakami, Y. Ninomiya, M. Takigawa, and T. Tsuji. 1998. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell Cardiol. 30:2411-2422.
10. Blom, I. E., A. J. van Dijk, R. A. de Weger, M. G. J. Tilanus, and R. Goldschmeding. 2001. Identification of human ccn2* (connective tissue growth factor) promoter polymorphism. J. Clin. Pathol.: Mol. Pathol. 54:192-196.
11. Abdi, R., T. T. B. Huong, A. Shagun-Ruiz, P. M. Murphy, B. M. Brenner, E. L. Milford, and D. H. McDermott. 2002. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J. Am. Soc. Nephrol. 13:754-758.
12. Ortlepp, J. R., K. Vesper, V. Mevissen, F. Schmitz, U. Janssens, A. Franke, P. Hanrath, C. Weber, K. Zerres, and R. Hoffmann. 2003. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J. Mol. Med. 81:363-367.
13. Ridker, P. M., R. J. Glynn, and C. H. Hennekens. 1998. C-reactive Protein adds to predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007-2011.
14. Cao, H., and R. A. Hegele. 2000. Human C-reactive protein (CRP) 1059 G/C polymorphism. J. Hum. Genet. 45:100-101.
15. Zee, R. Y. L., and P. M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:217-219.
16. Read, R. C., N. J. Camp, F. S. diGiovine, R. Borrow, E. B. Kaczmarski, A. G. A. Chaudhary, J. F. Andrew, and G. W. Duff. 2000. An Interleukin-1 genotype is associated with fatal outcome of menigococcal disease. J. Infect. Dis. 182:1557-1560.
17. Ma, P., D. Chen, J. Pan, and B. Du. 2002. Genomic polymorphism within interleukin-1 family cytokines influence the outcome of septic patients. Crit. Care Med. 30:1046-1050.
18. Brull, D. J., H. E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G. D. Lowe, and S. E. Humphries. 2001. Interleukin-6 gene 174G>C and 572G>C promoter polymorphism are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 21:1458-1463.
19. Ortlepp, J. R., J. Metrikat, K. Vesper, V. Mevissen, F. Schmitz, M. Albrecht, P. Maya-Pelzer, P. Hanrath, K. Zerres, and R. Hoffmann. 2003. The interleukin 6 promotor polymorphism is associated with elevated leukocytes and reduced physical fitness in young healthy smokers. J. Mol. Med. 81:578-584.
20. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963.
21. Schlüter, B., C. Raufhake, M. Erren, H. Schotte, F. Kipp, S. Rust, H. VanAken, G. Assmann, and E. Berendes. 2002. Effect of the interleukin-6 promotor polymorphism (174 G/C) on the incidence and outcome of sepsis. Crit. Care. Med. 30:32-37.
22. Burzetta, F., L. Iacoviello, A. DiCastenuovo, F. Glieca, N. Luciani, R. Zamparelli, R. Schiavello, M. B. Donati, A. Maseri, G. F. Possati, and F. Andreotti. 2001. Relation of the 174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 88:1125-1128.
23. D'Aiuto, F., J. P. Casas, T. Shab, S. E. Humphries, A. D. Hingorani, and M. S. Tonetti. 2005. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179:413-417.
24. Eklund, C., F. Jahan, T. Pessi, T. Lehtimaki, and M. Hurme. 2003. Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur. Cytokine Netw. 14:168-171.
25. Lee, S. H., C. G. Ihm, S. D. Sohn, T. W. Lee, M. J. Kim, G. Koh, S. J. Oh, J. T. Woo, S. W. Kim, J. W. Kim, Y. S. Kim, B. C. Lee, S. D. Kim, B. S. Cho, H. J. Lee, and J. H. Chung. 2004. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am. J. Nephrol. 24:410-414.
26. Halverstadt, A., D. A. Phares, S. Roth, R. E. Ferrell, A. P. Goldberg, and J. M. Hagberg. 2005. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim. Biophys. Acta 1734:143-151.
27. Vozarova, B., J. M. Fernandez-Real, W. C. Knowler, L. Gallart, R. L. Hanson, J. D. Gruber, W. Ricart, J. Vendrell, C. Richart, P. A. Tataranni, and J. K. Wolford. 2003. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum. Genet. 112:409-413.
28. Rundek, T., M. S. Elkind, J. Pittman, B. Boden-Albala, S. Martin, S. E. Humphries, S. H. Juo, and R. L. Sacco. 2002. Carotid intimamedia thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33:1420-1423.
29. Aegerter, P., A. Boumendil, A. Retbi, E. Minvielle, B. Dervaux, and B. Guidet. 2005. SAPS II revisited. Intensive Care Med. 31:416-423.
30. Editorial. 1999. Freely association. Nat. Genet. 22:1-2.